Inflammatory Bowel Disease and Risk of Major Bleeding During Anticoagulation for Venous Thromboembolism.

Background: Little is known about the bleeding risk in patients with inflammatory bowel disease (IBD) and venous thromboembolism (VTE) treated with anticoagulation. Our aim was to elucidate the rate of major bleeding (MB) events in a well-defined cohort of patients with IBD during anticoagulation after VTE.

Methods: This study is a retrospective follow-up analysis of a multicenter cohort study investigating the incidence and recurrence rate of VTE in IBD.

Length of hospital stay for TB varies with comorbidity and hospital location.

Although most guidelines overwhelmingly recommend outpatient TB treatment, hospitalisations are common. We investigated the proportion of TB patients hospitalised and determined factors associated with length of stay (LOS) in Switzerland. Cases with TB as the primary diagnosis were retrieved from a nation-wide hospitalisation database and compared to TB notifications.

[Hepatology scores].

We are performing a complex medicine in an environment of limited resources. Therefore we need to accurately diagnose, predict and treat. Many scores have been developed with these goals in Hepatology.